Group 3 and group 4 medulloblastoma (non-WNT/non-SHH)

What changed: Group 3 and group 4 medulloblastoma (non-WNT/non-SHH)

Cancer page →

Every dated change on the records linked to Group 3 and group 4 medulloblastoma (non-WNT/non-SHH), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Trial result1Milestone7This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordGroup 3 and group 4 medulloblastoma (non-WNT/non-SHH)
Facts on this page last checked
When this page itself was last checked or edited.

2021 · 3

2012 · 1

2012MilestoneGroup 3 and group 4 medulloblastoma (non-WNT/non-SHH)
Consensus on four molecular groups; group 3 and group 4 named
A milestone in how this cancer is treated.

2006 · 1

2006MilestoneCisplatin
A9961: 23.4 Gy craniospinal radiotherapy with cisplatin-based chemotherapy gives 81 percent five-year event-free survival
A milestone in how this cancer is treated.

2003 · 1

2003MilestoneGroup 3 and group 4 medulloblastoma (non-WNT/non-SHH)
SIOP PNET3: chemotherapy before radiotherapy improves event-free survival
A milestone in how this cancer is treated.

1953 · 1

1953MilestoneGroup 3 and group 4 medulloblastoma (non-WNT/non-SHH)
Craniospinal irradiation introduced for medulloblastoma
A milestone in how this cancer is treated.

1925 · 1

1925MilestoneGroup 3 and group 4 medulloblastoma (non-WNT/non-SHH)
Bailey and Cushing name medulloblastoma
A milestone in how this cancer is treated.